Literature DB >> 9140822

Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits.

S Matsui1, M L Fu, S Katsuda, M Hayase, N Yamaguchi, K Teraoka, T Kurihara, N Takekoshi, E Murakami, J Hoebeke, A Hjalmarson.   

Abstract

An experimental model of early-stage cardiomyopathy was created by immunizing rabbits for 1 year with synthetic peptides corresponding to the sequence of the second extracellular loop of either beta-adrenoceptors or M2-muscarinic receptors. Thirty male rabbits were used and divided into three groups: a control group (n = 10), a group immunized with the peptide corresponding to the beta-adrenoceptor (beta 1 group) (n = 10) and a group immunized with the peptide corresponding to the M2-muscarinic receptor (M2 group) (n = 10). If the sera from both groups of immunized rabbits high-titres of anti-peptide antibodies were found throughout the study period but not in the sera from control rabbits or in the preimmune sera of immunized rabbits. No significant cross-reaction with peptides other than those used for immunization was found. The myocardial receptor density of both immunized groups displayed a strong trend toward receptor up-regulation. This was significant in the beta 1 group but not in the M2 group. Both groups of immunized rabbits displayed significantly enlarged ventricles and thinner walls, as compared with the control group. However, in contrast to the beta 1 group, which showed enlarged cavities in both left and right ventricles, the M2 group was mainly affected in the right ventricles. Moreover, morphological examinations of the hearts of rabbits from both immunized groups demonstrated focal myofibrillar lysis, loss of myofilament, mitochondrial swelling and condensation, sarcoplasmic vacuolation, deposition of dense granules in the sarcoplasm and the myofibrils. One of the sex control rabbit hearts which were examined showed mild degenerative changes in the myocardium and scant mononuclear cell infiltration. However, when all the control rabbit hearts were examined by electron microscopy, no significant alterations were found. These results suggest that immunization by peptides, corresponding to the target sequences for anti-receptor autoantibodies in idiopathic dilated cardiomyopathy, induces morphological changes in the heart similar to those found in the human disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9140822     DOI: 10.1006/jmcc.1996.0307

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  31 in total

1.  Phenotype of early cardiomyopathic changes induced by active immunization of rats with a synthetic peptide corresponding to the second extracellular loop of the human beta-adrenergic receptor.

Authors:  L Buvall; E Bollano; J Chen; W Shultze; M Fu
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

2.  Cardiac gene expression and systemic cytokine profile are complementary in a murine model of post-ischemic heart failure.

Authors:  S Lachtermacher; B L B Esporcatte; F Montalvão; P C Costa; D C Rodrigues; L Belem; A Rabischoffisky; H C C Faria Neto; R Vasconcellos; S Iacobas; D A Iacobas; H F R Dohmann; D C Spray; R C S Goldenberg; A C Campos-de-Carvalho
Journal:  Braz J Med Biol Res       Date:  2010-03-06       Impact factor: 2.590

Review 3.  Autoantibodies as Endogenous Modulators of GPCR Signaling.

Authors:  Meredith A Skiba; Andrew C Kruse
Journal:  Trends Pharmacol Sci       Date:  2020-12-24       Impact factor: 14.819

Review 4.  Autoantibodies and cardiovascular dysfunction: cause or consequence?

Authors:  Yuji Nagatomo; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2014-12

Review 5.  Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases.

Authors:  Gerd Wallukat; Ingolf Schimke
Journal:  Semin Immunopathol       Date:  2014-04-29       Impact factor: 9.623

6.  Implications of a vasodilatory human monoclonal autoantibody in postural hypotension.

Authors:  Hongliang Li; Jonathan Zuccolo; David C Kem; Caitlin Zillner; Jiyeon Lee; Kenneth Smith; Judith A James; Madeleine W Cunningham; Xichun Yu
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

7.  Adoptive passive transfer of rabbit beta1-adrenoceptor peptide immune cardiomyopathy into the Rag2-/- mouse: participation of the ER stress.

Authors:  Jiahao Liu; Weike Mao; Chikao Iwai; Shuji Fukuoka; Raju Vulapalli; Huanlei Huang; Tingchung Wang; Virendra K Sharma; Shey-Shing Sheu; Michael Fu; Chang-Seng Liang
Journal:  J Mol Cell Cardiol       Date:  2007-11-24       Impact factor: 5.000

8.  Darbepoetin alfa exerts a cardioprotective effect in autoimmune cardiomyopathy via reduction of ER stress and activation of the PI3K/Akt and STAT3 pathways.

Authors:  Weike Mao; Chikao Iwai; Jiahao Liu; Shey-Shing Sheu; Michael Fu; Chang-Seng Liang
Journal:  J Mol Cell Cardiol       Date:  2008-05-27       Impact factor: 5.000

9.  Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy.

Authors:  Roland Jahns; Valérie Boivin; Lutz Hein; Sven Triebel; Christiane E Angermann; Georg Ertl; Martin J Lohse
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

10.  Immunoadsorption therapy for patients with dilated cardiomyopathy and heart failure.

Authors:  Uichi Ikeda; Hiroki Kasai; Atsushi Izawa; Jun Koyama; Yoshikazu Yazaki; Masafumi Takahashi; Makoto Higuchi; Chang-Sung Koh; Keiji Yamamoto
Journal:  Curr Cardiol Rev       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.